Frontiers in CNS Drug Discovery

Frontiers in CNS Drug Discovery

Volume: 3

Frontiers in CNS Drug Discovery is a book series devoted to publishing reviews which highlight the latest advances in drug design and discovery for disorders of the central nervous system (CNS). ...
[view complete introduction]

US $
30

*(Excluding Mailing and Handling)



Calpain Inhibition: A Potential Therapeutic Target for Neurodegenerative and Neuromuscular Disorders

Pp. 33-71 (39)

Getaw Worku Hassen, Leo Kesner, Alfred Stracher and Abraham Shulman

Abstract

Proteases are involved in different neurodegenerative and neuromuscular disorders. The role of protease inhibitors as therapeutic agents has been the matter of intense research. Given the role of proteases in these diseases, it is appealing to develop a single agent as a “magic bullet” that would target all the disease states. Calpain inhibitors have been tested with success in animal models of human diseases. In this review, we summarize the role of calpain in selected neurodegenerative and neuromuscular diseases. We describe the various instances in which calpain has been implicated and discuss the results of calpain inhibition in each disease entity as well as how targeted calpain inhibition could be beneficial. The focus of this review is to highlight the potential role of targeted inhibition as a therapeutic option and to introduce three newer calpain inhibitors with unique characteristics.

Keywords:

Calcium, Calpain, Calpain inhibitors, CNS, Cyclin-dependent kinase, Excitotoxicity, Muscular dystrophy, Neurodegeneration, Targeted-calpain inhibition.

Affiliation:

Department of Emergency Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA.